Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cosciens Biopharma Inc (CSCI.TO)

Cosciens Biopharma Inc (CSCI.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
COSCIENS Biopharma: Q4 Earnings Snapshot

COSCIENS Biopharma: Q4 Earnings Snapshot

CSCI.TO : 2.28 (+43.40%)
COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

TORONTO, ONTARIO, March 25, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“ COSCIENS ” or the “ Company ”), a life science company focused on the development of...

CSCI.TO : 2.28 (+43.40%)
CSCIF : 1.7300 (+50.43%)
Upcoming Meeting Dates - March 23, 2026

Toronto, Ontario--(Newsfile Corp. - March 23, 2026) - The following is a list of Upcoming Meeting Dates announced this week for Reporting Issuers in Canada. The data is supplied by Issuing Companies through...

VPT.VN : 0.115 (unch)
LCFS.TO : 7.35 (+5.00%)
TSND.TO : 0.94 (+3.30%)
BR.TO : 0.71 (+2.90%)
WED.VN : 23.300 (-2.10%)
EDR.TO : 13.30 (-0.45%)
MRMD.CN : 0.0950 (unch)
PRQ.TO : 2.03 (+4.10%)
SEA.TO : 41.99 (-0.50%)
MHUB.VN : 0.600 (-4.76%)
GPG.VN : 0.420 (-2.33%)
CAMB.VN : 1.450 (-3.33%)
COSCIENS Provides Strategic Update

TORONTO, ONTARIO, March 05, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) (“ COSCIENS ” or the “ Company ”) today announced that the Company has made a strategic...

CSCI.TO : 2.28 (+43.40%)
CSCIF : 1.7300 (+50.43%)
Upcoming Meeting Dates - February 23, 2026

Toronto, Ontario--(Newsfile Corp. - February 23, 2026) - The following is a list of Upcoming Meeting Dates announced this week for Reporting Issuers in Canada. The data is supplied by Issuing Companies...

ELD.TO : 49.88 (-0.66%)
SCD.VN : 0.135 (-3.57%)
STE.VN : 0.440 (-2.22%)
WPRT.TO : 2.62 (-1.13%)
GMTN.VN : 1.830 (-4.94%)
WGO.VN : 1.550 (-3.73%)
ISGI.VN : 0.010 (unch)
SLF.TO : 88.50 (+1.33%)
VGZ.TO : 2.84 (-1.05%)
ARX.TO : 27.66 (+1.99%)
WPM.TO : 188.85 (-0.67%)
CRI.VN : 0.145 (-3.33%)
COSCIENS Announces Exclusive Distribution Agreement with Wuzhou Drug International for Macrilen® in Hainan-Guangdong-Hong Kong-Macao Greater Bay Area and Singapore

TORONTO, ONTARIO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) (“ COSCIENS ” or the “ Company ”), a life sciences company focused on pharmaceutical therapies,...

CSCI.TO : 2.28 (+43.40%)
CSCIF : 1.7300 (+50.43%)
CSCI : 2.72 (-11.69%)
COSCIENS Biopharma Inc. Announces Leadership Change

TORONTO, ONTARIO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) (“COSCIENS” or the “Company”), a life science company focused on natural ingredients and...

CSCI.TO : 2.28 (+43.40%)
CSCI : 2.72 (-11.69%)
COSCIENS Biopharma: Q3 Earnings Snapshot

COSCIENS Biopharma: Q3 Earnings Snapshot

CSCI.TO : 2.28 (+43.40%)
COSCIENS Biopharma Inc. Reports Third Quarter 2025 Financial Results and Provides Strategic Initiatives Update

COSCIENS voluntarily delists from Nasdaq, while retaining the Company’s listing on the TSX COSCIENS restructuring results in significantly lower cash outflow with operating expenses down 59% vs....

CSCI.TO : 2.28 (+43.40%)
CSCI : 2.72 (-11.69%)
COSCIENS Biopharma: Q2 Earnings Snapshot

COSCIENS Biopharma: Q2 Earnings Snapshot

CSCI.TO : 2.28 (+43.40%)

Barchart Exclusives

1 Low-Risk, High-Reward Way to ‘Just Do It’ and Trade Nike Stock with Options
When there’s an iconic brand, a blue-chip stock, down more than 70% from its peak price, and I can still own it with a downside risk level I define myself? “Just Do It” sings in my ears. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.